A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

ClinicalTrials.gov ID: NCT07071519

Public ClinicalTrials.gov record NCT07071519. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 10, 2026, 9:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Open-Label Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Ulcerative Colitis

Study identification

NCT ID: NCT07071519
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: AbbVie; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Ulcerative Colitis

Interventions

Risankizumab Drug

Drug

Eligibility (public fields only)

Age range: 2 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 27, 2025
Primary completion: Jun 30, 2034
Completion: Jun 30, 2034
Last update posted: May 7, 2026

2025 – 2034

United States locations

U.S. sites: 10
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
Phoenix Children's Hospital /ID# 273015	Phoenix	Arizona	85016	Recruiting
University of California San Francisco - Mission Bay /ID# 273022	San Francisco	California	94158	Recruiting
Nicklaus Children'S Hospital - Miami - Southwest 62nd Avenue /ID# 271585	Miami	Florida	33155	Recruiting
Childrens Center For Digestive Health Care /ID# 273228	Atlanta	Georgia	30342	Recruiting
University of Chicago Medical Center /ID# 271588	Chicago	Illinois	60637	Recruiting
Goryeb Children's Hospital /ID# 271801	Morristown	New Jersey	07962	Recruiting
University Hospitals Cleveland Medical Center /ID# 271831	Cleveland	Ohio	44106	Recruiting
The Children's Hospital of Philadelphia /ID# 273222	Philadelphia	Pennsylvania	19104	Recruiting
Upmc Children'S Hospital Of Pittsburgh /ID# 272328	Pittsburgh	Pennsylvania	15224	Recruiting
Patewood Medical Campus /ID# 272477	Greenville	South Carolina	29615	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07071519, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2026 · Synced May 10, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07071519 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →